Who we are

Turning complexity into possibility

We are a global specialty biopharmaceutical company dedicated to developing treatments for complex healthcare challenges. By decoding the science behind rare disease, we continue to deliver innovative therapies to those who need them most.

Our philosophy

At JCR, we recognize that “Life is Rare.” Every life holds irreplaceable value and each patient’s story is unique. It’s this that drives us to develop transformative treatments for the most complex healthcare challenges.

Founded in Japan in 1975, our focus on understanding even the most intricate science means we continue to redefine the boundaries of healthcare. Already, our unique approach has led us to create numerous breakthrough therapies, including the world’s first approved fusion protein that can pass through the blood-brain barrier. Because we believe that the hope of a better future should include everyone.

Company snapshot

Founded in Japan in 1975, we take pride in doing things differently. Our unique approach has led us to create numerous breakthrough therapies, including the world’s first approved fusion protein that can pass through the blood-brain barrier.

3 worldwide subsidiaries

the USA, Europe and Brazil

First global approval

for a CNS treatment using JCR’s proprietary J-Brain Cargo® blood-brain barrier-penetrating technology

60% of employees

engage in research, development or biomanufacturing

3 key global partnerships

Alexion, Angelini Pharma and Modalis

Vision and
values

Putting people first

Our community is our priority. Patients, families and physicians and our employees are at the heart of what we do.

Forging our own path

Unshackled from convention, we create new solutions no one else can.

Always advancing

We don’t stand still. Our research continuously pushes boundaries to deliver for patients and families.

Committed to excellence

We deliver the highest standards for partners, patients and employees.

Leadership

Senior Executive Directors

Toru Ashida

Representative Director,
Chairman

Hiroyuki Sonoda, Ph.D.

Representative Director,
President,
Chief Scientific Officer

Andrea Spezzi, M.D., FFPM

Director,
Senior Managing
Executive Officer

Yoshio Hiyama, Ph.D.

Director,
Managing Executive Officer,
Executive Director,
Quality Assurance Division

Shin Ashida

Director, Founder

Corporate Officers

Yutaka Honda

Senior Managing
Executive Officer,
Executive Director,
Administration Division,
Head of Executive Office

Toshihiro Ishikiriyama

Senior Managing
Executive Officer,
Executive Director,
Business Development Division

Yoh Ito

Managing Executive Officer,
Executive Director,
Corporate Strategy Division

Makoto Ashida

Managing Executive Officer,
Executive Director,
Production Division

Anne Bechet

Managing Executive Officer,
Executive Director,
Development Division,
JCR Europe B.V.
General Manager,
JCR USA Inc. CEO

Takayo Egawa

Senior Executive Officer,
Director,
International Affairs Office

Tomohiko Miyagawa

Executive Officer,
Executive Director,
Sales Division

Kazutoshi Mihara

Executive Officer,
Executive Director,
Research Division
and Director,
CMC Research Institute

Hiroyuki Fukuya

Executive Officer, Director,
Legal and
Compliance Department,
Internal Control Department,
Chief Legal and
Compliance Officer

Internal Board Members